Proteinases and myocardial extracellular matrix turnover

Molecular and Cellular Biochemistry

Volumn 168, Issue 1-2, 1997, Pages 1-12

  Tyagi, Suresh C ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Cancer; Cardiomyopathy; Collagen; Collagenase; Elastin; Gelatinase; Growth factor; Heart; Ischemia; Matrix metalloproteinase; Proteoglycans; Remodeling; Structure function; Tissue inhibitor of metalloproteinase; Vascular

Indexed keywords

ASPARTIC PROTEINASE; COLLAGENASE; CYSTEINE PROTEINASE; GELATINASE; GROWTH FACTOR; HEART ENZYME; HORMONE; MATRIX METALLOPROTEINASE; PROTEINASE; PROTEINASE INHIBITOR; SCLEROPROTEIN; SERINE PROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; ENZYME SPECIFICITY; EXTRACELLULAR MATRIX; HEART FAILURE; HEART INFARCTION; HEART MUSCLE METABOLISM; HEART VENTRICLE REMODELING;

EID: 0031040522     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006850903242     Document Type: Article

References (90)

1. Borg TK, Burgess ML: Holding it all together: organization and function (s) of the extracellular matrix of the heart. Heart Failure 8: 230-238, 1993
2. Tyagi SC, Bheemanathini V, Mandi D, Reddy HK, Voelker DJ: Role of extracellular matrix in cardiac remodeling. Heart Failure Reviews 1: 73-80, 1996
3. Weber KT, Sun Y, Tyagi SC, Cleutjens J: Collagen network of the myocardium: Function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol 26: 279-292, 1994
4. Factor SM, Robinson TF: Comparative connective tissue structure-function relationships in biologic pumps. Lab Invest 58: 150-156, 1988
5. Royce PM, Steinmann B (eds). Connective Tissue and Its Heritable Disorders. Molecular Genetic, and Medical Aspects. Wiley-Liss Inc., New York, 1993
6. Matrisian LM: Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6: 121-5, 1990
7. Alexander CM, Werb Z : Proteinases and extracellular matrix remodeling. Curr Opin Cell Biol 1: 974-982, 1989
8. Laurent GJ: Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass. Am J Physiol 252: C1-C9, 1987
9. Brilla CG, Janicki JS, Weber KT: Impaired diastolic function and coronary reserve in genetic hypertension: role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ Res 69: 107-115, 1991
10. Tyagi SC, Campbell SE, Reddy HK, Tjahja E, Voelker DJ: Matrix metalloproteinase activity expression in infarcted, noninfarcted and dilated cardiomyopathic human hearts. Mol Cell Biochem 155: 13-21, 1996
11. Tyagi SC, Meyer L, Schmaltz RA, Reddy HK, Voelker DJ: Proteinases and restenosis in human coronary artery: extracellular matrix production exceeds the expression of proteolytic activity. Atherosclerosis 116: 43-57, 1995
12. Sato S, Ashraf M, Millard RW, Fujiwara H, Schwartz A: Connective tissue changes in early ischemia of porcine myocardium: an ultrastructural study. J Mol Cell Cardiol 15: 261-75, 1983
13. Graf J, Iwamoto M, Martin GR, Kleinman HK, Robey FA, Yamada Y: Identification of an amino acid sequence in laminin mediating cell attachment, chemotaxis, and receptor binding. Cell 48: 989-996, 1987
14. Eghbali M, Tomek R, Woods C, Bhambi B: Cardiac fibroblasts are predisposed to convert into myocyte phenotype: specific effects of TGFβ. Proc Nat Acad Sci (USA) 88: 795-799, 1991
15. Zak R: Cell proliferation during cardiac growth. Am J Cardiol 31: 211-219, 1973
16. Pfeffer JM, Pfeffer MA, Fishbein MC, Frohlich ED: Cardiac function and morphology with aging in the spontaneously hypertensive rat. Am J Physiol 6: H461-H468, 1979
17. Neurath H: Evolution of proteolytic enzymes. Science 224: 350-357, 1984
18. Tang J, Evolution in the structure and function of carboxyl proteases, Mol Cell Biochem 26: 93, 1979
19. Tyagi SC: Inhibitors of HIV-1 protease. Biochem & Cell Biol 70: 309-315, 1992
20. Khosla MC, Page IH, Bumpus FM: Interrelations between various blood pressure regulatory systems and the mosaic theory of hypertension. Biochem Pharmacol 28: 2867, 1979
21. Waterlow Jc, Garlick PJ, Millward DJ: Protein Turnover in Mammalian Tissues and the Whole Body. North-Holland Amsterdam, 1978
22. Schwartz MK, 1995, Tissue cathepsin as tumor marker. Clin Chim 237: 67-78, 1995
23. Wallin M, Deinulll J, Goobar L, Danielson UH: Proteolytic cleavage of microtubule-associated proteins by retroviral proteinases. J Gen Virol 71: 185-191, 1990
24. Goldspink DF, Lewis SEM: Age and activity related changes in three proteinase enzymes of rat skeletal muscle. Biochem J 230: 833-836, 1985
25. Barrett AJ: An introduction to the proteinases. In: AJ Barrett and G Salvesen (eds). Proteinases Inhibitors. Elsevier Science Publishers, Amsterdam, 1986, pp 3-22
26. Kirschke H, Barrett AJ: The chemistry of lysosomal proteases. In: H Glaumann and FJ Ballard (eds). Lysosomes: Their Role in Protein Breakdown. Academic Press, New York, 193-238, 1987
27. Eeckhout Y, Vaes G: Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation. Biochem J 166: 21-31, 1977
28. Carrell RW, Travis J: A family of serpin. Trends Biochem Sci 10: 20, 1985
29. Tyagi SC, Simon SR: Inhibitors directed to binding domain in neutrophil elastase. Biochemistry 29: 9970-9977, 1990
30. Bieth JG: In: RP Mecham (ed). Biology of Extracellular Matrix: Regulation of Matrix Accumulation. Academic Press, Orlando, FL, 1986, pp 217-320
31. Capodici C, Muthukumaran G, Amoruso MA, Berg RA: Activation of neutrophil collagenaase by cathepsin G. Inflammation 13: 245-258, 1989
32. Reddi AH, Extracellular matrix and development. In: KA Piez and AH Riddi (eds). Extracellular Matrix Biochemistry. New York, Elsevier, 1984, pp 375-412
33. Grillo HC, Gross J: Collagenolytic activity during mammalian wound repair. Dev Biol 15: 300-317, 1967
34. Eisen AZ: Human skin collagenase: localization and distribution in normal human skin. J Invest Dermatol 52: 442-8, 1969
35. Blair HC, Teitelbaum SL, Ehlich LS and Jeffrey JJ: Collagenase production by smooth muscle: Correlation of immunoreactive with functional enzyme in the myometrium. J Cell Physiol 129: 111-123, 1986
36. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327-36, 1991
37. Krane SM, Conca W, Stephenson ML, Amento EP, Goldring MB: Mechanisms of matrix degradation in rheumatoid artheritis. Ann NY Acad Sci 580: 340-354, 1990
38. Roe JL, Farach HA Jr, Strittmatter WJ, Lennarz WJ: Evidence for involment of metalloproteinases in a step in sea urchin gamate fusion. J Cell Biol 107: 539-544, 1988
39. Gross J, Nagai Y: Specific degradation of the collagen molecule by tadpole collagenolytic enzyme. Proc Natl Acad Sci (USA) 54: 1197-1204, 1965
40. Welgus HG, Jeffrey JJ, Stricklin GP, Eisen AZ: The gelatinolytic activity of human skin fibroblast collagenase. J Biol Chem 257: 11534-11539, 1982
41. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seilki M: A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370: 61-65, 1994
42. Henriet P, Rousseau GG, Eeckhout Y, Cloning and sequencing of mouse collagenase cDNA. FEBS 310: 175-178, 1992
43. Quinn CO, Scott DK, Brinckoff CF, Matrisian LM, Jeffrey JJ, Partridge NC, Rat Collagenases: Cloning amino acid sequence camparison, and parathyroid hormone regulation in osteoblastic cells. J Biol Chem 265: 22342-22347, 1990
44. Woessner JF Jr: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5: 2145-2154, 1991
45. McKerrow JH: Human fibroblast collagenase contains an amino acid sequence homologous to the zinc-binding site of Serratia proteinase. J Biol Chem 262: 5943, 1987
46. Emmert-Buck MR, Emoilard HP, Corcoran ML, Krutzsch HC, Foidart JM, Stetler-Stevenson WG: Cell surface binding of TIMP-2 and pro-MMP-2/TIMP-2 complex. FEBS Lett 364: 28-32, 1995
47. Fields GB, Netzel-Arnett SJ, Windsor LJ, Engler JA, Birkdal-Henson H, van Wart HE: Proteolytic activities of human fibroblast collagenase: Hydrolysis of a broad range of substrate at a single site. Biochemistry 29: 6670-6677, 1990
48. Hasty AK, Pourlllotabbed TF, Goldberg GI, Thompson JP, Spinella DG, Stevens RM, Mainardi CL: Human neutrophil collagenase: A distinct gene product with homology to other matrix metalloproteinases. J Biol Chem 265: 11421-11424, 1990
49. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI: SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identified to that secreted by normal human macrophages. J Biol Chem 264: 17213-17221, 1989
50. Werb Z: In: WN Kelley, ED Harris, S Ruddy, CB Sledge (eds). Textbook of Rheumatology. 3rd ed, Saunders WB, Philadelphia, 1989, pp 300-321
51. Gadher SJ, Eyre DR, Duance VC, Wotton SF, Heck LW, Schmid TM, Woolley DE: Susceptibility of cartilage collagens type II, IX, X, and XI to human synovial collagenase and neutrophil elastase. Eur J Biochem 175: 1-7, 1988
52. Tryggvason K, Hoyhtya M, Salo T: Proteloytic degradation of extracellular matrix in tumor invasion. Biochim Biophys Acta 907: 191-217, 1987
53. Werb Z, Hembry RM, Murphy G, Aggeller J: Commitment to expression of the metalloproteinases, collagenase and stromelysin: Relationship to inducing and to change in cytoskeletal architecture. J Cell Biol 102: 689-702, 1986
54. Nagase H, Enghild JJ, Suzllki K, Salvesen G: Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate. Biochemistry 29: 5783-9, 1990
55. Matrisian LM, Hogan BL, Growth factor-regulated proteases and extracellular matrix remodeling during mammalian development. Curr Top Develop Biol 24: 219-259, 1990
56. Okamura K, Sato Y, Matsuda T, Hamanaka R, Ono M, Kohno K, Kuwano M: Endodenous basic fibroblasts growth factor-dependent induction of collagenase and interleukin-6 tumor necrosis factor-treated human microvascular endothelial cells. J Biol Chem 266: 19162-19165, 1991
57. Dayer JM, Roelke MS, Krane SM: Effects of PGE2, indomethacin, trifluoperazine and drugs affecting the cytoskeleton on collagenase production by cultured adherent rheumatoid synovial cells. Biochem Pharmacol 33: 2893-2899, 1984
58. Fisher WD, Golds EE, van der Rest M, Cooke TD, Lyons HE, Poole AR: Stimulation of collagenase secretion from rheumatoid synovial tissue by human collagenpeptides. J Bone Joint Surg. Americam Volume 64: 546-557, 1982
59. Tyagi SC, Kumar SG, Alla SR, Reddy HK, Voelker DJ, Janicki JS: Extracellular matrix regulation of metalloproteinase and antiproteinase in human heart fibroblast cells. J Cell Physiol 167: 137-147, 1996
60. Brenner DA, O'Hara M, Angel P, Chojkier M, Karin M: Prolonged activation of jun and collagenase genes by TNF-α Nature (London) 337: 661-663, 1989
61. Yang-Yen, HF, Chambard JC, Sun YL, Smeal T, Schmidt TJ, Drouin J, Karin M: Transcriptional interference between c-Jun and the gluocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62: 1205-1215, 1990
62. Schule R, Rangarajan P, Kllewer S, Ransone LJ, Bolado J, Yang N, Verma IM, Evans RM: Functional antogonism between oncoprotein c-jun and the glucocorticoid receptor. Cell 62: 1217-1226, 1990
63. 73 active-site zinc complex in latency and a 'cystein switch' mechanism for activation. Proc Natl Acad Sci USA 87: 364-8, 1990
64. Tyagi SC, Ratajska A, Weber KT: Myocardial matrix metalloproteinases: activation and localization. Mol Cell Biochem 126: 49-59,1993
65. Lyons RM, Gentry LE, Purchio AF, Moses HL: Mechansim of activation of latent recombinant TGF-β by plasmin. J Cell Biol 110: 1361-1367, 1990
66. Lennarz WJ, Strittmatter WJ: Cellular functions of metallo-endoproteinases. Biochim Biophys Acta 1071: 149-158, 1991
67. Walakovits LA, Moore VL, Bharadwaj N, Gallick GS, Lark MW: Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury. Arthritis and Rheumatism 35: 35-42, 1992
68. Flenniken AM, Wiliams BRG: Developmental expression of the endogenous TIMP gene and a TIMP-lacZ fusion gene in transgenic mice. Genes Dev 4: 1094-1106, 1990
69. Gavrilovic J, Hembry RM, Reynolds JJ, Murphy G: Tissue inhibitor of metalloproteinases (TIMPs) regulates extracellular type I collagen degradation by chondrocytes and endothelial cells. J Cell Sci 87: 357-362, 1987
70. Okada Y, Watanabe S, Nakanishi I, Kishi J, Hayakawa T, Watorek W et al.: Inactivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other serine proteinases. FEBS Lett 229: 157-60, 1988
71. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K: Growth-promoting activity of TIMP-1 for a wide range of cells. FEBS Lett 298: 29-32, 1992
72. Tyagi SC, Meyer L, Kumar SG, Schmaltz RA, Reddy HK, Voelker DJ: Induction of tissue inhibitor of metalloproteinase and its mitogenic response to endothelial cells in human atherosclerotic and restenotic lesions. Canad J Cardiol 12: 353-362, 1996
73. Leco, KJ, Khokha R, Pavloff N, Hawkes SP, Edwards DR: Tissue inhibitor of metalloproteinase-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 269: 9352-9360, 1994
74. Unemori EN, Boullana K, Werb Z: Vectorial secretion of extracellular matrix proteins, matrix degrading proteinases, and tissue inhibitor of metalloproteinases by endothelial cells. J Biol Chem 265: 445-451, 1990
75. Gross J, Lapiere CM: Collagenolytic activity in amphibian tissue. Proc Natl Acad Sci (USA) 48: 1014-1022, 1962
76. Roe TL, Lennarz WJ: Biosynthesis and secretion of the hatching enzyme during sea urchin embryogenesis. J Biol Chem 265: 8704-8711, 1990
77. Blood CH, Zetter BR: Vasculature, angiogenesis and tumor metastasis. Biochem Biophys Acta 1032: 89-118, 1990
78. Woessner JE Jr, Morioka N, Zhu C, Mukaida T, Butler T, LeMaire WJ: Connective tissue breakdown in ovulation. Steroids 54: 491-499, 1989
79. Delaise JM, Eeckhout Y, Sear C, Galloway A, McCullagh K, Vaes G: A new synthetic inhibitor of mammalian tissue collagenases inhibits bone resorption in culture. Biochem Biophys Res Commun 133: 483-490, 1985
80. Tyagi SC, Matsubara L, Weber KT: Direct extraction and estimation of collagenase(s) activity by zymography in microquantities of rat myocardium and uterus. Clin Biochem 26: 191-198, 1993
81. Tyagi SC, Kumar SG, Glover G: Induction of tissue inhibitor and matrix metalloproteinase by serum in human heart-derived fibroblast and endomyocardial endothelial cells. J Cell Biochem 58: 360-371, 1995
82. Tyagi SC, Kumar SG, Borders S: Reduction-oxidation (Redox) state regulation of extracellular matrix metalloproteinases and tissue inhibitors in cardiac normal and transformed fibroblast cells. J Cell Biochem 61: 139-147, 1996
83. Bonnin CM, Sparrow MP, Taylor RR: Collagen synthesis and content in right ventricular hypertrophy in the dog. Am J Physiol 10: H703-H713, 1981
84. Charney RH, Takahashi S, Zhao M, Sonnenblick EH, Eng C: Collagen loss in the stunned myocardiuln. Circulation 85: 1483-1490, 1992
85. Montfort I, Perez-Tamayo R: The distribution of collagenase in normal rat tissues. J Histochem Cytochem 23: 910-20, 1975
86. Chakraborty A, Eghbali M: Collagenase activity in the normal rat myocardium: an immunohistochemical method. Histochemistry 92: 391-6, 1989
87. Woolley DE, Tetlow LC, Evanson JM: Collagenase immunolocalization studies of rheumatoid and malignant tissue. In: DE Woolley, JM Evanson (eds). Collagenases in Normal and Pathological Connective Tissues. John Wiley & Sons, New York, 1980, pp 103-125
88. Tyagi SC, Kulllar SG, Banks J, Fortson W: Co-expression of tissue inhibitor and matrix metalloproteinase in myocardium. J Mol Cell Cardiol 27: 2177-2189, 1995
89. Tyagi SC, Kumar S, Cassatt S, Parker JL: Temporal expression of extracellular matrix metalloproteinases and tissue plasminogen activator in the development of collateral vessels in canine model of coronary occlusioll. Canad J Physiol and Pharmacol 74: 7-19, 1996
90. Williamson RA, Marston FAO, Angal S, Koklitis P, Panico M, Morris HR, Carne AF, Smith BJ, Harris TJR, Freedman RB: Disulfide bond assignment in human tissue inhibitor of metalloproteinases (TIMP). Biochem J 268: 267-274, 1990